Streetbeat News

NSRGF

Nestle SA

https://www.nestle.com/

CEO

Ulf Schneider

Industry

Dry, Condensed, and Evaporated Dairy Product Manufacturing

Open

102.37

Mkt cap

264B

Volume

370

High

102.75

P/E Ratio

21.63

52-wk high

110.96

Low

102.37

Div yield

0.03

52-wk low

79.55

Nestlé's Q4 organic sales growth exceeded expectations, driven by balanced price increases and robust real internal growth. The company anticipates improved organic sales growth for FY25, focusing on balanced price increases amid rising commodity costs. The Fuel for Growth program aims for significant cost savings.

Portfolio Pulse from

March 09, 2025 | 9:00 am

Nestle's new CEO aims to tackle growth challenges through operational efficiencies and brand optimization, targeting 4%+ organic growth and 17%+ margins. Despite a reasonable valuation, growth prospects are limited.

Portfolio Pulse from

March 02, 2025 | 2:00 pm

Nestlé S.A. held its Q4 2024 earnings call, discussing the company's financial performance and outlook. Key participants included CEO Laurent Freixe and CFO Anna Olive Manz, with analysts from major banks attending.

Portfolio Pulse from

February 13, 2025 | 2:45 pm

Nestle's CEO defended the company's packaged food products, emphasizing their safety, quality, and role in reducing waste, in response to potential criticism from incoming U.S. health secretary Robert F. Kennedy Jr.

Portfolio Pulse from

February 13, 2025 | 9:00 am

Nestlé is facing challenges such as reduced pricing power and FX headwinds, but maintains strong volumes. Despite rising debt, it remains manageable. The stock is trading at a significant discount, making it an attractive buy with a 4% dividend yield.

Portfolio Pulse from

January 27, 2025 | 4:00 pm

Nestle has faced a challenging 2024, missing sales growth expectations and cutting guidance multiple times. Despite this, the company is positioned to improve, with shares down 30% year-to-date. Modest free cash flow growth could justify the current price.

Portfolio Pulse from

December 19, 2024 | 7:45 pm

Nestle has introduced a new line of protein shots and drinks, called Boost Pre-meal, designed to support individuals using weight-loss medications like GLP-1 receptor agonists. This move is part of Nestle's strategy to capitalize on the growing weight-loss market.

Portfolio Pulse from

December 18, 2024 | 4:00 pm

Nestle is introducing protein shots in the US aimed at weight-loss drug users, targeting the growing market for weight-loss products.

Portfolio Pulse from

December 18, 2024 | 6:30 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.